ARI joins iPSpine project

25. February 2019

​AO Research Institute Davos takes key role in new iPSpine project

Group picture of participants in the Horizon 2020 iPSpine project kick-off

The AO Research Institute Davos (ARI) has joined 19 partners in a five-year project titled iPSpine (induced pluripotent stem cell based therapy for spinal regeneration). 

The kick-off meeting took place in Utrecht, The Netherlands on February 12-13. ARI scientists Sibylle Grad, Marianna Peroglio, and Mauro Alini are all involved in the project, which comes under the European Union's Horizon 2020 program to fund research into advanced therapies.

This study looks specifically at chronic lower back pain, which is a leading cause of disability and morbidity across the globe, affecting over 700 million people each year. This project aims to develop treatments that will help restore spinal function.

ARI has a significant role within the iPSpine project, as the newly developed cell- and material-based treatments will be tested using ARI's well-established whole intervertebral disc organ culture system.

The project consortium includes 20 partners based in Europe, the United States of America, and China. Find out more.